Association of Kidney Damage Markers with Bleeding Risk in CKD and Atrial Fibrillation During Rivaroxaban Treatment
Ranokhon IgamberdievaTashkent Pediatric Medical Institute, Tashkent, Tashkent Province, Uzbekistan;Sherzod AbdullaevRepublican Specialized Scientific and Practical Medical Center for Nephrology and Kidney Transplantation, Tashkent, Tashkent Province, Uzbekistan
ABI
Аннотация
Аннотация мавжуд эмас.
Мавзулар
Идентификаторлар
Иқтибослар ва манбалар
0 та иқтибос0 та фойдаланилган манба
Кўрсаткичлар — AkademScholar · Тез орада